Ramin Akhavan - 23 Mar 2022 Form 4 Insider Report for DermTech, Inc.

Role
General Counsel
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
23 Mar 2022
Net transactions value
$0
Form type
4
Filing time
25 Mar 2022, 20:09:31 UTC
Previous filing
07 Jan 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Award $0 +59,097 +185% $0.000000 90,988 23 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve thirty-sixths (12/36) of the restricted stock units shall vest on March 5, 2023 and (ii) the remaining twenty-four thirty-sixths (24/36) shall vest in eight (8) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following March 5, 2023 until the final vesting date on March 5, 2025.
F2 Includes 660 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.